By George Glover
Investors are snapping up the three stocks that are set to join the Nasdaq 100 next week, judging by premarket action.
Shares in software developer Palantir Technologies climbed 0.9% ahead of Monday's opening bell. Business intelligence company-turned-Bitcoin buyer MicroStrategy jumped 5.8%, and Taser manufacturer Axon Enterprise gained 2.8%.
The moves higher came after the Nasdaq 100 added the three stocks as part of its annual reconstitution. The changes, announced Friday evening, will take effect before the market opens on Dec. 23.
MicroStrategy's gains likely reflect its close association with Bitcoin, which hit an all-time high above $106,000 early Monday. The company is the largest corporate holder of the token and carries on buying, funding its purchases by selling shares and convertible bonds.
Palantir, MicroStrategy, and Axon have all racked up triple-digit gains this year, making them the nonfinancial companies with the highest market values in the Nasdaq Composite index that weren't yet part of the Nasdaq 100.
They're set to replace vaccine developer Moderna, server maker Super Micro Computer, and biotech company Illumina in the tech-heavy gauge. All three of those stocks were falling on Monday -- Moderna slid 0.5% ahead of the U.S. open, while Super Micro tumbled 11.8% and Illumina dropped 1.2%.
Write to George Glover at george.glover@dowjones.com
This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 16, 2024 06:17 ET (11:17 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.